# A Two-Stage Localization and Refinement Neural Network Structure for Data-Efficient Microbleed Detection

**Authors:** Lukas Rau, Oliver Granert, Nils G. Margraf, Stephan Schneider, Ulf Jensen-Kondering

PMC · DOI: 10.3390/brainsci16020207 · Brain Sciences · 2026-02-10

## TL;DR

This paper introduces a two-stage AI system that can detect brain microbleeds using only a small dataset, making it accessible for smaller medical facilities.

## Contribution

The novel two-stage neural network workflow enables high sensitivity for CMB detection with minimal training data.

## Key findings

- The proposed method achieved 97.5% sensitivity for detecting cerebral microbleeds using only 15 MRI scans.
- The two-stage approach combines a 3D U-Net and a 3D CNN to first localize and then refine CMB detection.
- The system can be trained effectively with a small dataset, making it suitable for smaller radiological facilities.

## Abstract

Background/Objectives: In medical diagnostics, (semi-)automatic detection of pathological structures in images is becoming increasingly important. In particular, detecting cerebral microbleeds (CMBs) poses a challenge in clinical practice because the process is time-consuming and prone to error. Methods: Compared to previous methods of (semi-) automatic CMB detection that rely on large training datasets, we propose a method that can be adapted with a small dataset while still performing well. We propose a workflow that uses a two-stage approach to detect cerebral microbleeds that can be trained with a small dataset. The first stage is a 3D U-Net that retrieves potential CMB locations in the SWI image volume. Then, a 3D convolutional neural network (CNN) is used for discrimination to distinguish between real CMB and CMB mimics. Results: Using a dataset of 15 MRI scans with 40 marked CMBs, we are able to achieve a sensitivity of 97.5%. Conclusions: We showed that it is possible to create a workflow with high sensitivity using only a few training samples, enabling smaller radiological facilities to train networks using their own datasets. Even though the workflow performs well on a small dataset, it still requires further testing with other larger datasets.

## Full-text entities

- **Diseases:** axonal injury (MESH:D001480), cognitive decline (MESH:D003072), CAA (MESH:D016657), hemorrhages (MESH:D006470), cerebrovascular diseases (MESH:D002561), vascular diseases (MESH:D014652), HTN-A (MESH:D006973), injury to (MESH:D014947), hemorrhagic metastasis (MESH:D009362), CMBs (MESH:D002547)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938630/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938630/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938630/full.md

---
Source: https://tomesphere.com/paper/PMC12938630